Thus, our studies suggested that first, gal-1 can function both intracellularly and extracellularly, and second, gal-1 might regulate the phenotypes of cancer stem cells through activation of COX-2/PGE2 and Akt/mTOR pathways. The gene discussed is MTOR; the disease is cancer.